Vitamin D (25-OH) in Gulf War Illness

In Gulf War Illness (GWI, Gulf War Syndrome), the direction of change for Vitamin D (25-OH), also described as Calcidiol, is inconsistent across studies that used healthy Gulf War veteran controls as the reference group. Symptom domains tied to this marker in the source include immune modulation. The finding is drawn from Gean et al. 2021; it describes group-level differences, not a threshold that classifies an individual.

↕ InconsistentMetabolicLOINC 1989-3

Summary

Direction in Gulf War Illness↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryMetabolic
Also described asCalcidiol
Compared againstHGV (healthy Gulf War veteran controls)
Associated symptomsImmune modulation
Test typeBlood test (serum / plasma / whole blood)
LOINC code1989-3
SourceGean et al. 2021 — doi:10.1016/j.lfs.2021.119456
Condition atlasGulf War Illness Biomarker Atlas

Other conditions where Vitamin D (25-OH) is reported

See the cross-condition hub: Vitamin D (25-OH) across conditions.

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Levels of vitamin D (5 registered trials use a matching outcome measure).

Clinical trials using Vitamin D (25-OH) as an outcome

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Commercial test availability

Vitamin D, 25-Hydroxy — commercial laboratory test.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Also sold as a nutrient or supplement

Vitamin D3 (cholecalciferol) (vitamin). 25-OH vitamin D is the measured metabolite; D3 is the common supplement form. This tag means the analyte is also available orally; it is not a product endorsement and a low or high level does not by itself justify supplementation.

Related Metabolic markers in Gulf War Illness

Full list: Gulf War Illness Biomarker Atlas.

Frequently asked questions

Is Vitamin D (25-OH) high or low in Gulf War Illness?

Mixed. Some studies report higher and others lower Vitamin D (25-OH) in Gulf War Illness compared with healthy Gulf War veteran controls, so no single direction is established. Source: Gean et al. 2021.

What symptoms is Vitamin D (25-OH) associated with in Gulf War Illness?

The cited literature associates this marker with Immune modulation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Vitamin D (25-OH)?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 1989-3. Commercial laboratories such as Quest Diagnostics, LabCorp, Ulta Lab Tests list an orderable assay.

Is one abnormal Vitamin D (25-OH) result diagnostic of Gulf War Illness?

No. No single biomarker is diagnostic of Gulf War Illness. Vitamin D (25-OH) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Vitamin D (25-OH) specific to Gulf War Illness?

No. The same marker is also reported in Long COVID in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Vitamin D (25-OH) in Gulf War Illness: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/gulf-war-illness/vitamin-d-25-oh.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from gulf-war-illness.json · Browse: Gulf War Illness atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.